- Home
- XTNT vs VRCA Comparison
XTNT vs VRCA Comparison
Compare XTNT & VRCA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- XTNT
- VRCA
- Stock Information
- Founded
- XTNT N/A
- VRCA 2013
- Country
- XTNT United States
- VRCA United States
- Employees
- XTNT N/A
- VRCA N/A
- Industry
- XTNT Biotechnology: Biological Products (No Diagnostic Substances)
- VRCA Biotechnology: Pharmaceutical Preparations
- Sector
- XTNT Health Care
- VRCA Health Care
- Exchange
- XTNT Nasdaq
- VRCA Nasdaq
- Market Cap
- XTNT 60.9M
- VRCA 54.0M
- IPO Year
- XTNT N/A
- VRCA 2018
- Fundamental
- Price
- XTNT $0.61
- VRCA $0.58
- Analyst Decision
- XTNT
- VRCA Hold
- Analyst Count
- XTNT 0
- VRCA 5
- Target Price
- XTNT N/A
- VRCA $6.00
- AVG Volume (30 Days)
- XTNT 57.0K
- VRCA 254.0K
- Earning Date
- XTNT 08-07-2025
- VRCA 08-13-2025
- Dividend Yield
- XTNT N/A
- VRCA N/A
- EPS Growth
- XTNT N/A
- VRCA N/A
- EPS
- XTNT N/A
- VRCA N/A
- Revenue
- XTNT $122,298,000.00
- VRCA $7,179,000.00
- Revenue This Year
- XTNT $11.64
- VRCA $171.87
- Revenue Next Year
- XTNT $7.59
- VRCA $71.38
- P/E Ratio
- XTNT N/A
- VRCA N/A
- Revenue Growth
- XTNT 20.81
- VRCA N/A
- 52 Week Low
- XTNT $0.33
- VRCA $0.38
- 52 Week High
- XTNT $0.83
- VRCA $8.98
- Technical
- Relative Strength Index (RSI)
- XTNT 48.62
- VRCA 49.82
- Support Level
- XTNT $0.57
- VRCA $0.60
- Resistance Level
- XTNT $0.68
- VRCA $0.71
- Average True Range (ATR)
- XTNT 0.05
- VRCA 0.07
- MACD
- XTNT -0.02
- VRCA -0.00
- Stochastic Oscillator
- XTNT 30.44
- VRCA 43.69
About XTNT Xtant Medical Holdings Inc.
Xtant Medical Holdings Inc is a medical technology company focused on the design, development, and commercialization of a comprehensive portfolio of orthobiologics and spinal implant systems to facilitate spinal fusion in complex spine, deformity and degenerative procedures. Its products are used by orthopedic spine surgeons and neurosurgeons to treat a variety of spinal disorders in the cervical, thoracolumbar, and interbody spine. The company's biomaterial products include OsteoSponge, OsteoSponge SC, OsteoSelect Plus DBM putty, OsteoWrap, and the line of 3Demin products, as well as other allografts. It generates a majority of its revenue from the US.
About VRCA Verrica Pharmaceuticals Inc.
Verrica Pharmaceuticals Inc is a dermatology therapeutics company engaged in the development and commercialization of novel treatments that provide a meaningful benefit for people living with skin diseases. Its product candidate, VP-102, is developed for the treatment of molluscum contagiosum, or molluscum, a contagious and pediatric viral skin disease, and common warts.